Pravachol, Pravastatin

Pravachol, Pravastatin Newswire

Comprehensive Real-Time News Feed for Pravachol, Pravastatin (generic).

Results 1 - 20 of 48 in Pravachol, Pravastatin (generic)

  1. Article ImageRead the original story w/Photo

    Tuesday May 19 | Western morning News

    Cholesterol-lowering drugs such as statins have been found to cut people's risk of stroke by nearly a third. Cholesterol-lowering drugs such as statins have been found to cut people's risk of stroke by nearly a third.

    Comment?

  2. Statins 'slash stroke risk by 30%'Read the original story w/Photo

    Tuesday May 19 | Somerset County Gazette

    Cholesterol-lowering drugs such as statins have been found to cut people's risk of stroke by nearly a third. A study carried out in France found that those who take either statins or fibrates had a 30% lower risk.

    Comment?

  3. Myrtle Potter & Company Announces Engagement With Esperion...Read the original story

    Wednesday May 6 | BioSpace

    "We have a history of working with pharmaceutical and biotech companies to maximize the commercial value of their innovative products," said , CEO. "We are eager to couple Esperion's lipid-regulating drug development expertise with our commercialization expertise as we work together to successfully commercialize the ETC-1002 portfolio."

    Comment?

  4. Myrtle Potter & Company Announces Engagement with Esperion...Read the original story

    Thursday May 7 | Freshnews

    Myrtle Potter & Company, LLC, a life science and healthcare advisory firm specializing in corporate strategy, product development and product commercialization, today announced the Company has been engaged by Esperion Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of hypercholesterolemia, to guide and develop the commercialization strategies for the ETC-1002 portfolio. Founded in 2005 by Myrtle Potter, Myrtle Potter & Company specializes in devising novel strategies to maximize the value of prescription drug brands and portfolios.

    Comment?

  5. Survey: Patients increasingly hit with low reimbursement for genericsRead the original story w/Photo

    Apr 7, 2015 | Business Journal

    Patients are more often getting hit with low reimbursement rates from insurers when they fill their prescriptions, according to a new survey of 700 pharmacists by Alexandria-based National Community Pharmacists Association.

    Comment?

  6. Zydus Pharmaceuticals USA Inc. - Strategic SWOT Analysis Review - New Market Study PublishedRead the original story

    Mar 21, 2015 | PR-inside.com

    Zydus Pharmaceuticals USA Inc. is a pharmaceutical company. The company develops, manufactures, and sells generic pharmaceutical products.

    Comment?

  7. Esperion Therapeutics Announces Positive Top-Line Phase 2b Results...Read the original story

    Mar 17, 2015 | Freshnews

    Esperion Therapeutics, Inc. , an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral low-density lipoprotein cholesterol lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today announced positive top-line results from ETC-1002-009, a Phase 2b study evaluating the efficacy and safety of ETC-1002 compared with placebo in patients with hypercholesterolemia on stable statin therapy. Top-line results showed the 12-week study met its primary endpoint of greater LDL-cholesterol lowering from baseline with ETC-1002 compared with placebo.

    Comment?

  8. Abstract P151: Duration and Types of Statin Use and Long-Term Risk of ...Read the original story

    Mar 4, 2015 | Circulation

    Introduction: Although effective for cardiovascular disease prevention, statin use has been associated with an elevated risk of type 2 diabetes . However, data on duration of use and types of statins are still limited.

    Comment?

  9. Abstract P219: Lesser LDL Drop on Statins Predicts Greater Glycemic...Read the original story

    Mar 4, 2015 | Circulation

    Background: Statins elevate glucose in some people, but effects vary. Age & metabolic syndrome precursors were previously shown to significantly predict glc rise on statins in men but not women.

    Comment?

  10. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Read the original story

    Mar 8, 2015 | CiteULike

    Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis are common causes of elevated liver enzymes in the general population. NASH and to some extent NAFLD have been associated with increased liver-related and all-cause mortality.

    Comment?

  11. Drug and medical cost effects of a drug formulary change with...Read the original story

    Mar 5, 2015 | CiteULike

    Drug and medical cost effects of a drug formulary change with therapeutic interchange for statin drugs in a multistate managed Medicaid organization. Therapeutic interchange interventions are commonly used to manage pharmacy benefit costs.

    Comment?

  12. Synthetic biology breakthrough leads to cheaper statin productionRead the original story

    Mar 3, 2015 | Medical News Today

    University of Manchester researchers, together with industrial partner DSM, have developed a single-step fermentative method for the production of leading cholesterol-lowering drug, pravastatin, which will facilitate industrial-scale statin drug production. In a study published in Proceedings of the National Academy of Sciences , the researchers have devised a single-step fermentative method for the industrial production of the active drug pravastatin that previously involved a costly dual-step fermentation and biotransformation process.

    Comment?

  13. It is hard for people to swallow pills they can't affordRead the original story w/Photo

    Mar 2, 2015 | Kevin, M.D.

    Cholesterol pills are one of the great medical advances I've witnessed during my professional career. I am talking specifically about a category of medications called statins, drugs like Lipitor and Pravachol.

    Comment?

  14. Guidelines suggest blood thinners for more women, seniors with AFibRead the original story w/Photo

    Mar 2, 2015 | PhysOrg Weblog

    Nearly all women and people over 65 in the U.S. with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis from the Duke Clinical Research Institute. Atrial fibrillation, or AFib, is an irregular heartbeat that can lead to blood clots, stroke, heart failure and other heart-related complications.

    Comment?

  15. Urine test could lead to better treatment of bladder cancerRead the original story

    Feb 27, 2015 | Science Daily

    A simple urine test could help to guide clinicians in the treatment of bladder cancer patients, researchers believe. Being able to reliably identify those patients with the most aggressive cancers early via urine tests, and expediting aggressive therapeutic strategies, may significantly improve outcomes, they say.

    Comment?

  16. New approach to assessing effectiveness of anti-cancer drugsRead the original story

    Feb 27, 2015 | Science Daily

    Scientists have a developed a new method to monitor the effect of anti-cancer drugs on very rare leukemia stem cells. The approach potentially allows doctors to screen patients and personalize their treatment.

    Comment?

  17. Synthetic biology breakthrough leads to cheaper statin productionRead the original story

    Feb 27, 2015 | Science Daily

    Researchers have developed a single-step fermentative method for the production of leading cholesterol-lowering drug, pravastatin, which will facilitate industrial-scale statin drug production. University of Manchester researchers, together with industrial partner DSM, have developed a single-step fermentative method for the production of leading cholesterol-lowering drug, pravastatin, which will facilitate industrial-scale statin drug production.

    Comment?

  18. Cardiac and respiratory function supported by abdominal muscles in muscular dystrophyRead the original story

    Feb 27, 2015 | Science Daily

    The muscular dystrophies are known to target various muscle groups differentially. In addition to making limb muscles weak, muscular dystrophy can also lead to decreased function of specific muscles involved in respiration causing breathing difficulties as well as leading to cardiac problems.

    Comment?

  19. Single-step fermentative method for the production of cholesterol-lowering drug pravastatinRead the original story w/Photo

    Feb 27, 2015 | PhysOrg Weblog

    In a study published in Proceedings of the National Academy of Sciences , the researchers have devised a single-step fermentative method for the industrial production of the active drug pravastatin that previously involved a costly dual-step fermentation and biotransformation process. Reprogramming the antibiotics-producing fungus Penicillium chrysogenum, with discovery and engineering of a cytochrome P450 enzyme involved in the hydroxylation of the precursor compactin, enabled high level fermentation of the correct form of pravastatin to facilitate efficient industrial-scale statin drug production.

    Comment?

  20. DRL faces US probe on pricingRead the original story

    Feb 25, 2015 | The Telegraph

    Hyderabad, Feb. 25 : The attorney generals of Texas and California have separately sought information on the pricing of some drugs sold by Dr Reddy's Laboratories in the US, according to the latest filing of the drug maker with the US Securities and Exchange Commission . The development comes after two members of United States Congress wrote to the company, requesting information and expressing "concern" over the "escalating prices" of two products - divalproex sodium ER and pravastatin sodium - marketed by it in the US.

    Comment?